Publications (208) Publications in which a researcher has participated


  1. Anexo 2. La Medalla de la Real Academia de Medicina de Salamanca

    Historia de la RAMSA : 50º aniversario (1971-2021) (Ediciones Universidad de Salamanca), pp. 295-299

  2. Crk proteins activate the Rap1 guanine nucleotide exchange factor C3G by segregated adaptor-dependent and -independent mechanisms

    Cell Communication and Signaling, Vol. 21, Núm. 1

  3. Inherited Thrombocytopenia Caused by Variants in Crucial Genes for Glycosylation

    International journal of molecular sciences, Vol. 24, Núm. 6

  4. Key Genes of the Immune System and Predisposition to Acquired Hemophilia A: Evidence from a Spanish Cohort of 49 Patients Using Next-Generation Sequencing

    International Journal of Molecular Sciences, Vol. 24, Núm. 22

  5. Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis

    Blood, Vol. 141, Núm. 4, pp. 406-421

  6. Presente y futuro de la Real Academia de Medicina de Salamanca

    Historia de la RAMSA : 50º aniversario (1971-2021) (Ediciones Universidad de Salamanca), pp. 239-248

  7. Presidentes

    Historia de la RAMSA : 50º aniversario (1971-2021) (Ediciones Universidad de Salamanca), pp. 55-111

  8. Synchronous colorectal cancer and abdominal aortic aneurysm treated simultaneously. Is a one-stage surgery a feasible treatment?

    Acta Chirurgica Belgica, Vol. 123, Núm. 3, pp. 325-328

  9. Two historic endovascular surgeries. The anticipated future

    Angiologia, Vol. 75, Núm. 2, pp. 117-119

  10. Vascular ceroplastic



  1. A novel nonsense variant in TPM4 caused dominant macrothrombocytopenia, mild bleeding tendency and disrupted cytoskeleton remodeling

    Journal of Thrombosis and Haemostasis, Vol. 20, Núm. 5, pp. 1248-1255

  2. Arterial resection-repair as part of the resection of a carotid paraganglioma

    Angiologia, Vol. 74, Núm. 3, pp. 115-118

  3. C3G down-regulation enhances pro-migratory and stemness properties of oval cells by promoting an epithelial-mesenchymal-like process

    International journal of biological sciences, Vol. 18, Núm. 15, pp. 5873-5884

  4. Clinical Efficacy and Safety of Fanhdi®, a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, Vol. 28

  5. Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT)

    Medicina Clinica, Vol. 158, Núm. 2, pp. 82-89

  6. Diagnostic and therapeutic protocol for thoracic aortic aneurysms

    Angiologia, Vol. 74, Núm. 5, pp. 227-233

  7. Direct oral anticoagulants in the treatment of venous thromboembolic disease associated with cancer. Evidence and recommendations

    Angiologia, Vol. 74, Núm. 2, pp. 51-65

  8. Echocardiographic Prediction of Successful Weaning From Venoarterial Extracorporeal Membrane Oxygenation

    American journal of critical care : an official publication, American Association of Critical-Care Nurses, Vol. 31, Núm. 6, pp. 483-493

  9. Endoglin and Other Angiogenesis Markers in Recurrent Varicose Veins

    Journal of Personalized Medicine, Vol. 12, Núm. 4

  10. First vascular suture: Hallowell-Lambert, 1759

    Angiologia, Vol. 74, Núm. 3, pp. 135-137